Pacing catheter with expandable distal end

• US 9,037,235 B2
• Filed: 06/15/2009
• Issued: 05/19/2015
• Est. Priority Date: 06/19/2008
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Tomaschko, Daniel K., Heidner, Matthew C., Broman, David James, Eidenschink, Tracee, Baynham, Tamara Colette
• Primary Examiner(s): Bertram, Eric D.
• Application Number:
  US12/484,727
• Publication Number:
  US 20090318990A1
• Time in Patent Office: 2,164 Days
• Field of Search: 607/9, 607/10, 607/122, 607/126
• US Class Current: 607/10
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/3625 External stimulators
• CPC Class Codes: A61N 2001/0585 Coronary sinus electrodes

Abstract

Cardioprotective pacing is applied to prevent and/or reduce cardiac injury associated with myocardial infarction (MI) and revascularization procedure. Pacing pulses are generated from a pacemaker and delivered through one or more pacing electrodes incorporated onto one or more percutaneous transluminal vascular intervention (PTVI) devices during the revascularization procedure. In one embodiment, a PTVI device includes an expandable distal end to provide a stable electrical contact between a pacing electrode and the vascular wall of a blood vessel when the distal end is placed in the blood vessel.

Claims

1. A percutaneous transluminal vascular intervention (PTVI) device assembly for use by a user during revascularization of a blood vessel, the PTVI device assembly comprising:

a sheath including a sheath proximal end portion, a sheath distal end portion configured for intravascular placement, an elongate sheath shaft coupled between the sheath proximal end portion and the sheath distal end portion, and a sheath lumen extending within the sheath shaft from the sheath proximal end portion to the sheath distal end portion, the sheath lumen including a proximal opening at the sheath proximal end portion and a distal opening at the sheath distal end portion;

a pacing lead including a lead proximal end portion, a lead distal end portion, and an elongate lead shaft coupled between the lead proximal end portion and the lead distal end portion, the pacing lead configured to allow the lead distal end portion to enter the sheath lumen through the proximal opening and exit from the sheath lumen through the distal opening by pushing the pacing lead into the sheath lumen, the lead distal end portion configured to self-expand after exiting from the sheath lumen and including one or more pacing electrodes; and

an external pacemaker connected to the lead proximal end portion, the pacemaker including;

a pacing output circuit delivering pacing pulses through the one or more pacing electrodes;

a control circuit coupled to the pacing output circuit and configured to execute a cardioprotective pacing protocol specifying one or more cardiac protection pacing sequences each including alternating pacing and non-pacing periods, the pacing periods each having a pacing duration during which a plurality of the pacing pulses is timed to be delivered according to a stress augmentation pacing mode to augment myocardial mechanical stress to a level effecting cardioprotection against myocardial injury, the non-pacing periods each having a non-pacing duration during which none of the pacing pulses is timed to be delivered;

a chassis housing the pacing output circuit and the control circuit;

a user interface incorporated onto the chassis, the user interface configured to allow control of the delivery of the pacing pulses by the user; and

a pacing protocol module detachably connected to the external pacemaker,

wherein the cardioprotective pacing protocol is stored in the pacing protocol module and specifies the stress augmentation pacing mode with pacing parameters including an atrioventricular delay selected to augment the myocardial mechanical stress to the level effecting cardioprotection against myocardial injury.

2. The PTVI device assembly of claim 1, wherein the sheath comprises one or more further pacing electrodes.

3. The PTVI device assembly of claim 1, wherein the pacing lead is configured to allow the lead distal end portion to retract into the sheath lumen through the distal opening and exit the sheath lumen from the proximal opening by pulling the pacing lead from the lumen.

4. The PTVI device assembly of claim 3, wherein the pacing lead comprises:

one or more connectors at the lead proximal end portion; and

one or more conductors each providing electrical connection between one of the one or more pacing electrodes and one of the one or more connectors.

5. The PTVI device assembly of claim 4, wherein the lead distal end portion is configured to expand upon exiting from the sheath lumen and contract upon being retracted into sheath lumen.

6. The PTVI device assembly of claim 4, wherein the lead distal end portion comprises a wire that springs into a coil when the lead distal end portion exits from the sheath lumen from the distal opening, and the one or more pacing electrodes comprise at least a portion of the wire.

7. The PTVI device assembly of claim 4, wherein the lead distal end portion comprises a plurality of wires each being substantially unbiased when the lead distal end portion is in the sheath lumen and biased when the distal end portion has exited from the sheath lumen from the distal opening.

8. The PTVI device assembly of claim 7, wherein the wires each comprise a biased portion made of one or more memory materials.

9. The PTVI device assembly of claim 1, wherein the control circuit is configured to apply rapid, asynchronous pacing during each of the pacing periods.

10. The PTVI device assembly of claim 1, wherein the control circuit is configured to cause delivery of the pacing pulses at a rate substantially higher than an intrinsic heart rate during each of the pacing periods.

11. The PTVI device assembly of claim 10, wherein the stress augmentation pacing mode is a bradycardia pacing mode.

12. The PTVI device assembly of claim 10, wherein the stress augmentation pacing mode is an asynchronous pacing mode.

13. The PTVI device assembly of claim 1, wherein the one or more cardiac protection pacing sequences each include approximately 1 to 4 cycles of the alternating pacing and non-pacing periods.

14. The PTVI device assembly of claim 13, wherein the pacing periods are each in a range of approximately 30 seconds to 20 minutes, and the non-pacing periods are each in a range of approximately 30 seconds to 20 minutes.

15. The PTVI device assembly of claim 14, wherein the one or more cardiac protection pacing sequences each include 3 cycles of the alternating pacing and non-pacing periods, the pacing periods are each approximately 5 minutes, and the non-pacing periods are each approximately 5 minutes.

16. The PTVI device assembly of claim 13, wherein the pacing periods are each in a range of approximately 10 seconds to one minute, and the non-pacing periods are each in a range of approximately 10 seconds to one minute.

17. The PTVI device assembly of claim 16, wherein the one or more cardiac protection pacing sequences each include approximately 2 to 4 cycles of the alternating pacing and non-pacing periods, the pacing periods are each approximately 30 seconds, and the non-pacing periods are each approximately 30 seconds.

18. The PTVI device of claim 1, wherein the lead distal end portion is in an expanded state when not being restrained.